Published in Thorax on March 01, 2008
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J (2015) 1.65
Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res (2010) 0.89
Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry. BMJ Open Respir Res (2014) 0.89
International registry for idiopathic pulmonary fibrosis. Thorax (2008) 0.77
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 3.69
An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis (1989) 3.12
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis (1989) 3.08
Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med (1992) 2.91
Studies on cytochrome oxidase. Interactions of the cytochrome oxidase protein with phospholipids and cytochrome c. J Biol Chem (1975) 2.80
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax (1993) 2.33
Primary Pneumocystis carinii and cytomegalovirus infections. Lancet (1981) 2.23
Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology (2001) 2.20
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J (2009) 2.14
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis (1990) 2.02
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax (2004) 1.96
Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.85
Studies on cytochrome oxidase. 8. Preparation and some properties of cardiac cytochrome oxidase. J Biol Chem (1972) 1.84
Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med (1990) 1.83
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J (2003) 1.81
Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol (1997) 1.70
Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol (1979) 1.69
Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest (1991) 1.66
A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis (1986) 1.65
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J (2002) 1.63
The source and role of RANTES in interstitial lung disease. Eur Respir J (1997) 1.62
Deuterium nuclear magnetic resonance investigation of the effects of proteins and polypeptides on hydrocarbon chain order in model membrane systems. Proc Natl Acad Sci U S A (1978) 1.53
Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med (1996) 1.53
Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax (1985) 1.52
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J (2011) 1.52
Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis (1987) 1.52
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J (2009) 1.51
Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol (1997) 1.47
Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur J Clin Invest (2000) 1.46
Interactions of bilirubin with bovine serum albumin in aqueous solution. J Biol Chem (1970) 1.44
Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis. Eur Respir J (1999) 1.44
The complete amino acid sequence of bovine heart cytochrome C1. Biochem Biophys Res Commun (1980) 1.43
Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol (1994) 1.41
Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J Exp Med (1989) 1.39
Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology (2004) 1.38
Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med (1997) 1.38
GLUCOSE CATABOLISM IN THE ERGOT FUNGUS, CLAVICEPS PURPUREA. J Bacteriol (1960) 1.36
Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method. Am Rev Respir Dis (1988) 1.36
Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis (2005) 1.35
Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med (1994) 1.34
Low-temperature kinetics of the reaction of oxygen and solubilized cytochrome oxidase. Biochem J (1978) 1.32
Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis (1985) 1.32
How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med (1995) 1.31
Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med (1997) 1.31
Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology (2000) 1.31
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res (2000) 1.30
Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J (1993) 1.29
The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis (1993) 1.28
Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med (1991) 1.27
Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol (1993) 1.27
Kinetics of electron transfer between cardiac cytochrome c 1 and c. J Biol Chem (1973) 1.26
High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax (1992) 1.23
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol (2001) 1.22
Heme-heme interaction in cytochrome c oxidase: the cooperativity of the hemes of cytochrome c oxidase as evidenced in the reaction with CO. Arch Biochem Biophys (1974) 1.21
Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am Rev Respir Dis (1991) 1.21
Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax (2001) 1.18
Preparation and properties of cardiac cytochrome c 1 . J Biol Chem (1972) 1.17
Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax (1999) 1.17
Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 1.16
Studies on cytochrome oxidase. II. A reaction of cyanide with cytochrome oxidase in soluble and particulate forms. J Biol Chem (1966) 1.16
Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol (1994) 1.16
Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest (1990) 1.15
Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur Respir J (1999) 1.15
Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis (1989) 1.15
Temperature dependence of the electron spin-lattice relaxation rate from pulsed EPR of CUA and heme a in cytochrome c oxidase. Biophys J (1984) 1.14
Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J (2006) 1.14
Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) (2000) 1.13
Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol (1995) 1.13
Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol (1992) 1.12
The pleuropulmonary manifestations of the postcardiac injury syndrome. Chest (1983) 1.11
The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis. Clin Exp Immunol (1986) 1.11
Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.10
Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants. Thorax (1987) 1.10
Thermodynamic and EPR characteristics of a HiPIP-type iron-sulfur center in the succinate dehydrogenase of the respiratory chain. J Biol Chem (1976) 1.10
Nuclear magnetic resonance investigation of the cytochrome oxidase--phospholipid interaction: a new model for boundary lipid. Biochemistry (1979) 1.09
Acute interstitial pneumonia. Eur Respir J (2000) 1.09
Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis. J Clin Invest (1993) 1.09
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J (2009) 1.08
Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum (1997) 1.08
The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology (1998) 1.07
Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis (1991) 1.07
Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun (2001) 1.07
TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J Immunol (1994) 1.07
Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun (2003) 1.07
8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med (1998) 1.07
Studies on cytochrome oxidase. IX. Heme-copper interaction. J Biol Chem (1972) 1.06
Stereospecificity of certain soluble and particulate preparations of mitochondrial reduced nicotinamide-adenine dinucleotide dehydrogenase from beef heart. Nature (1965) 1.06
Electron nuclear double resonance of cytochrome oxidase: nitrogen and proton ENDOR from the 'copper' EPR signal. Biochim Biophys Acta (1978) 1.06
Binding of bilirubin with lipid. A possible mechanism of its toxic reactions in mitochondria. J Biol Chem (1970) 1.06
Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis (1991) 1.05
Amino acid sequence of subunit V of bovine heart cytochrome oxidase, the heme alpha-containing subunit. J Biol Chem (1979) 1.05
Controversies in hypersensitivity pneumonitis. Am Rev Respir Dis (1992) 1.05
"Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health (1998) 1.05
Purification, properties and reconstitutive activity of a DPHN dehydrogenase. Biochem Biophys Res Commun (1972) 1.04
Genetics of fibrosing lung diseases. Eur Respir J (2005) 1.02
HLA-DPB polymorphisms: Glu 69 association with sarcoidosis. Eur J Immunogenet (1996) 1.02
Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med (1994) 1.01